Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia–ischemia
- 17 June 2008
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 155 (4) , 1204-1211
- https://doi.org/10.1016/j.neuroscience.2008.05.059
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Neuroprotective potential of ceftriaxone in in vitro models of strokeNeuroscience, 2007
- Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotectionNeurobiology of Disease, 2006
- Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: Role of glutamate uptake and FK506 binding protein 12 kDaNeuroscience, 2006
- Dehydroascorbic acid prevents oxidative cell death through a glutathione pathway in primary astrocytesJournal of Neuroscience Research, 2005
- Altered expression of the glutamate transporter EAAT2b in neurological diseaseAnnals of Neurology, 2004
- Adeno-associated viral vector-mediated apoE expression in Alzheimer's disease mice: low CNS immune response, long-term expression, and astrocyte specificityFrontiers in Bioscience-Landmark, 2004
- Human Glioma Cells and Undifferentiated Primary Astrocytes That Express Aberrant EAAT2 mRNA Inhibit Normal EAAT2 Protein Expression and Prevent Cell DeathMolecular and Cellular Neuroscience, 2002
- [3H]Muscimol Binding to γ-Aminobutyric AcidAReceptors Is Upregulated in CA1 Neurons of the Gerbil Hippocampus in the Ischemia-Tolerant StateStroke, 2002
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortexNeuroscience Letters, 1989